Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs

作者: Trevor S. Arnold , Luke A. Wittenburg , Cynthia C. Powell

DOI: 10.1111/VOP.12079

关键词: Intraocular pressureNaltrexoneDosingPlaceboOnce dailyTear productionAnesthesiaMedicineSystemic absorptionCorneal SensitivityGeneral Veterinary

摘要: Objective To determine the effect of topical naltrexone 0.3% on tear production, corneal sensitivity, and film stability in normal brachycephalic dogs. Animals Studied Twenty-two dogs. Procedures Measurements production (Schirmer test I II), intraocular pressure (IOP), central sensitivity (CS), breakup time (TFBUT) were collected at 0, 1, 24 h after administration either (NTX) or placebo (SV). Naltrexone SV was then administered once daily for 1 week, above measurements repeated 7 days, again 7 days discontinuing medication. Owners scored degree comfort, redness, rubbing, squinting, tearing. Serum 24 h, to systemic concentrations. Results Owners reported no significant change detected serum all treated dogs 1-h postadministration (average: 908 pg/mL, range: 319–1570 pg/mL) two 1-week point. not 24-h There NTX STT1, STT2, IOP, CS, TFBUT. Conclusions Naltrexone is well tolerated safe when applied topically eye daily. did show any effects parameters as measured this study. At once, dosing systemically absorbed; however, absorption likely be clinically significant.

参考文章(39)
Mohammad H. Dastjerdi, Reza Dana, Corneal nerve alterations in dry eye-associated ocular surface disease. International Ophthalmology Clinics. ,vol. 49, pp. 11- 20 ,(2009) , 10.1097/IIO.0B013E31819242C9
S. Carrington, P. Bedford, J. Guillon, E. Woodward, Biomicroscopy of the tear film: the tear film of the pekingese dog. Veterinary Record. ,vol. 124, pp. 323- 328 ,(1989) , 10.1136/VR.124.13.323
I.S. Zagon, Joseph W. Sassani, Melissa A. Carroll, Patricia J. McLaughlin, Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits. Brain Research Bulletin. ,vol. 81, pp. 248- 255 ,(2010) , 10.1016/J.BRAINRESBULL.2009.10.009
Ian S. Zagon, Matthew S. Klocek, Joseph W. Sassani, David T. Mauger, Patricia J. McLaughlin, Corneal safety of topically applied naltrexone. Journal of Ocular Pharmacology and Therapeutics. ,vol. 22, pp. 377- 387 ,(2006) , 10.1089/JOP.2006.22.377
Claudia Hartley, David L. Williams, Vicki J. Adams, Effect of age, gender, weight, and time of day on tear production in normal dogs. Veterinary Ophthalmology. ,vol. 9, pp. 53- 57 ,(2006) , 10.1111/J.1463-5224.2005.00437.X
K.N. Gelatt, E.O. MacKay, Distribution of intraocular pressure in dogs. Veterinary Ophthalmology. ,vol. 1, pp. 109- 114 ,(1998) , 10.1046/J.1463-5224.1998.00024.X
M R Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, S M Tavangar, L Moezi, S Payabvash, A Karoon, H Hoseininik, D A Mann, K P Moore, A R Mani, A R Dehpour, Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats Gut. ,vol. 55, pp. 1606- 1616 ,(2006) , 10.1136/GUT.2005.076778
Darlene A. Dartt, Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Progress in Retinal and Eye Research. ,vol. 28, pp. 155- 177 ,(2009) , 10.1016/J.PRETEYERES.2009.04.003
Kathryn L. Good, David J. Maggs, Steven R. Hollingsworth, Randall H. Scagliotti, Richard W. Nelson, Corneal sensitivity in dogs with diabetes mellitus American Journal of Veterinary Research. ,vol. 64, pp. 7- 11 ,(2003) , 10.2460/AJVR.2003.64.7
Matthew S. Klocek, Joseph W. Sassani, Patricia J. McLaughlin, Ian S. Zagon, Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats Experimental Eye Research. ,vol. 89, pp. 686- 692 ,(2009) , 10.1016/J.EXER.2009.06.010